Imaging farnesyl protein transferase using a topologically activated probe

被引:5
作者
Pham, Wellington [1 ]
Pantazopoulos, Pamela [1 ]
Moore, Anna [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol, Mol Imaging Lab,Athinoula A Martinos Ctr Biomed I, Charlestown, MA 02129 USA
关键词
D O I
10.1021/ja063599x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We report on the development and application of a "smart" activatable peptide-based probe for detection of Ras-related farnesyl protein transferase (FPT). Upon farnesylation by FPT, the probe was brought close to a hydrophobic milieu and as a consequence emitted fluorescent light that could be detected by several media, such as fluorescence microscopy, a plate reader, and an optical imaging system. A FPT activity assay confirmed the specificity of the probe (IC50 = 1.2 μM) for FPT compared to that of the native peptide (IC50 = 0.17 μM). In addition, the probe has remarkable binding constant, Kd = 26 nM. The specificity of enzyme activation was proved in pure enzyme assays as well as in cell-based assays. Furthermore, the fluorescent enhancement of the probe was 30-fold stronger than the control peptide in a live cell assay. Copyright © 2006 American Chemical Society.
引用
收藏
页码:11736 / 11737
页数:2
相关论文
共 12 条
[1]   ISOPRENYLATION IS REQUIRED FOR THE PROCESSING OF THE LAMIN-A PRECURSOR [J].
BECK, LA ;
HOSICK, TJ ;
SINENSKY, M .
JOURNAL OF CELL BIOLOGY, 1990, 110 (05) :1489-1499
[2]  
BOS JL, 1989, CANCER RES, V49, P4682
[3]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413
[4]   The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells [J].
Crespo, NC ;
Ohkanda, J ;
Yen, TJ ;
Hamilton, AD ;
Sebti, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :16161-16167
[5]   BENZODIAZEPINE PEPTIDOMIMETICS - POTENT INHIBITORS OF RAS FARNESYLATION IN ANIMAL-CELLS [J].
JAMES, GL ;
GOLDSTEIN, JL ;
BROWN, MS ;
RAWSON, TE ;
SOMERS, TC ;
MCDOWELL, RS ;
CROWLEY, CW ;
LUCAS, BK ;
LEVINSON, AD ;
MARSTERS, JC .
SCIENCE, 1993, 260 (5116) :1937-1942
[6]   Farnesyl transferase inhibitors - a novel therapy for breast cancer [J].
Johnston, SRD ;
Kelland, LR .
ENDOCRINE-RELATED CANCER, 2001, 8 (03) :227-235
[7]   C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice [J].
McNamara, DJ ;
Dobrusin, E ;
Leonard, DM ;
Shuler, KR ;
Kaltenbronn, JS ;
Quin, J ;
Bur, S ;
Thomas, CE ;
Doherty, AM ;
Scholten, JD ;
Zimmerman, KK ;
Gibbs, BS ;
Gowan, RC ;
Latash, MP ;
Leopold, WR ;
Przybranowski, SA ;
SeboltLeopold, JS .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3319-3322
[8]  
Pham W, 2002, ANGEW CHEM INT EDIT, V41, P3659, DOI 10.1002/1521-3773(20021004)41:19<3659::AID-ANIE3659>3.0.CO
[9]  
2-Q
[10]   INTRAMOLECULAR FLUORESCENCE ENHANCEMENT - A CONTINUOUS ASSAY OF RAS FARNESYL - PROTEIN TRANSFERASE [J].
POMPLIANO, DL ;
GOMEZ, RP ;
ANTHONY, NJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (20) :7945-7946